CellChorus
CellChorus is a leader in visual AI for single-cell analysis, providing high-throughput dynamic analysis of individual cells using its proprietary TIMING™ platform. This technology quantifies spatiotemporal performance, cell activation, killing, movement, and interactions over time, enabling scientists to understand cellular function, state, and phenotype. The platform integrates with multi-omic profiling, such as single-cell RNA sequencing and flow cytometry, to link functional insights with molecular data. CellChorus serves top-25 biopharmaceutical companies, small-cap public biopharmaceutical companies, and early-stage therapy developers, with customers including organizations focused on Natural Killer (NK) cells, Chimeric antigen receptor (CAR) T cells, monoclonal antibodies (mAbs), SARS-CoV-2-specific T cells, and tumor-infiltrating lymphocytes (TIL). The company's technology is protected by issued patents and pending applications, including US/10,746,736.
CellChorus
CellChorus is a leader in visual AI for single-cell analysis, providing high-throughput dynamic analysis of individual cells using its proprietary TIMING™ platform. This technology quantifies spatiotemporal performance, cell activation, killing, movement, and interactions over time, enabling scientists to understand cellular function, state, and phenotype. The platform integrates with multi-omic profiling, such as single-cell RNA sequencing and flow cytometry, to link functional insights with molecular data. CellChorus serves top-25 biopharmaceutical companies, small-cap public biopharmaceutical companies, and early-stage therapy developers, with customers including organizations focused on Natural Killer (NK) cells, Chimeric antigen receptor (CAR) T cells, monoclonal antibodies (mAbs), SARS-CoV-2-specific T cells, and tumor-infiltrating lymphocytes (TIL). The company's technology is protected by issued patents and pending applications, including US/10,746,736.